Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Aguado de la Rosa, Carlos, Cruz Castellanos, Patricia, Lázaro-Quintela, Martín, Dómine, Manuel, Vázquez Estévez, Sergio, López-Vivanco, Guillermo, Fírvida Pérez, José Luis, Alonso Romero, José Luis, Ferrera Delgado, Lioba, García Girón, Carlos, Diz Taín, Pilar, Álvarez Álvarez, Rosa, Mut Sanchís, Pilar, Fernández Cantón, Inmaculada, Manrique Abós, Isabel, Martínez Aguillo, Maite, Gómez-Aldaraví Gutiérrez, Lorenzo, Ortega Granados, Ana Laura, Álvarez Cabellos, Ruth, García Sebastián, Arancha, García Sifuentes, Luis Fernando, Reguart, Noemí
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2022)
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2022)
Get full text
Journal Article